当前位置:首页 - 行情中心 - 亨迪药业(301211) - 财务分析

亨迪药业

(301211)

  

流通市值:12.56亿  总市值:50.23亿
流通股本:7200.00万   总股本:2.88亿

亨迪药业(301211)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.37亿元,每股收益0.13元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益239493.59万元,未分配利润29958.20万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产254226.43万元,负债14732.84万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入138,059,120.72663,025,874.35542,445,746.24405,758,580.58
营业总成本94,973,688.59467,721,232.76374,327,664.34273,390,128.3
营业利润44,340,764.81205,334,070.12171,168,058.78133,790,701.88
利润总额44,323,592.98202,816,100.34170,786,541.22133,645,437.1
净利润37,381,597.2176,116,201.67144,514,979.02113,038,868.41
其他综合收益----
综合收益总额37,381,597.2176,116,201.67144,514,979.02113,038,868.41
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,062,714,828.892,098,949,170.232,119,187,019.862,142,682,193.6
非流动资产合计479,549,434.74447,621,805.56379,696,150.53349,825,736.06
资产总计2,542,264,263.632,546,570,975.792,498,883,170.392,492,507,929.66
流动负债合计133,340,394.72175,141,355.55159,874,483.33185,666,162.36
非流动负债合计13,987,986.7714,744,778.8212,285,224.1312,294,337.35
负债合计147,328,381.49189,886,134.37172,159,707.46197,960,499.71
归属于母公司股东权益合计2,394,935,882.142,356,684,841.422,326,723,462.932,294,547,429.95
股东权益合计2,394,935,882.142,356,684,841.422,326,723,462.932,294,547,429.95
负债和股东权益合计2,542,264,263.632,546,570,975.792,498,883,170.392,492,507,929.66
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计121,441,224.56605,727,754.74506,313,229.59346,272,880.99
经营活动现金流出小计107,110,148.27468,664,279.03423,324,908.53298,936,785.96
经营活动产生的现金流量净额14,331,076.29137,063,475.7182,988,321.0647,336,095.03
投资活动现金流入小计11,114,035.31466,409377,510.8936,059.07
投资活动现金流出小计57,220,603.54207,935,114.16119,570,288.0783,437,292.84
投资活动产生的现金流量净额-46,106,568.23-207,468,705.16-119,192,777.18-83,401,233.77
筹资活动现金流入小计----
筹资活动现金流出小计-97,167,597.7896,000,00093,858,000
筹资活动产生的现金流量净额--97,167,597.78-96,000,000-93,858,000
汇率变动对现金及现金等价物的影响551,001.483,810,470.863,512,1832,026,722.98
现金及现金等价物净增加额-31,224,490.46-163,762,356.37-128,692,273.12-127,896,415.76
期末现金及现金等价物余额1,663,102,024.221,694,226,514.681,729,396,597.931,730,192,455.29
TOP↑